2024
DOI: 10.1002/jnr.25303
|View full text |Cite
|
Sign up to set email alerts
|

Increased plasma lipocalin‐2 levels are associated with nonmotor symptoms and neuroimaging features in patients with Parkinson's disease

Yongyan Fan,
Xiaohuan Li,
Jianjun Ma
et al.

Abstract: Lipocalin‐2 (LCN2) is essential for the regulation of neuroinflammation and cellular uptake of iron. This study aimed to evaluate plasma LCN2 levels and explore their correlation with clinical and neuroimaging features in Parkinson's disease (PD) patients. Enzyme‐linked immunosorbent assay (ELISA) was used to measure plasma LCN2 levels in 120 subjects. Evaluation of motor symptoms and nonmotor symptoms in PD patients was assessed by the associated scales. Voxel‐based morphometry (VBM) was used to evaluate brai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 84 publications
(93 reference statements)
0
0
0
Order By: Relevance
“…There is accumulating evidence for a strong association between PD and GI disturbances, including intestinal inflammation. Analyses of immune profiles in the stools of PD patients demonstrate higher levels of inflammatory mediators suggestive of GI inflammation (Fan et al, 2024; Hor et al, 2022; Houser et al, 2018; Mulak et al, 2019; Schwiertz et al, 2018). Clinical studies further reveal that people with inflammatory bowel disease and GI infections have an increased risk of developing PD later in life (Fu et al, 2020; Houser et al, 2018; Lee et al, 2021; Liu et al, 2003; Nerius et al, 2020; Shen et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…There is accumulating evidence for a strong association between PD and GI disturbances, including intestinal inflammation. Analyses of immune profiles in the stools of PD patients demonstrate higher levels of inflammatory mediators suggestive of GI inflammation (Fan et al, 2024; Hor et al, 2022; Houser et al, 2018; Mulak et al, 2019; Schwiertz et al, 2018). Clinical studies further reveal that people with inflammatory bowel disease and GI infections have an increased risk of developing PD later in life (Fu et al, 2020; Houser et al, 2018; Lee et al, 2021; Liu et al, 2003; Nerius et al, 2020; Shen et al, 2017).…”
Section: Introductionmentioning
confidence: 99%